cerca CERCA
Giovedì 01 Dicembre 2022
Aggiornato: 07:01
Temi caldi

Chimica_E_Farmacia Salute_E_Benessere Salute_E_Benessere Chimica_E_Farmacia Economia_E_Finanza Chimica_E_Farmacia

comunicato stampa

Alimentiv, Summit Clinical Research Announce Collaboration to drive Non-Alcoholic Steatohepatitis (NASH) Clinical Trials

LONDON, ON, Nov. 3, 2022 /PRNewswire/ -- Alimentiv Inc. ("Alimentiv") and Summit Clinical Research, LLC ("Summit") today announced a strategic alliance to drive Non-Alcoholic Steatohepatitis (NASH) drug development programs forward faster and more efficiently. NASH is a growing global epidemic with no approved treatments. There are over 100 drugs in clinical development (Fraile et al., 2021). Current challenges include optimizing end-point assessment, minimizing screen failures, and improving rec...

ora in
Prima pagina
in Evidenza